Ritalin, or methylphenidate hydrochloride, is central nervous system stimulant. It is used to treat attention deficit hyperactivity disorder, ...
Barr Laboratories has initiated a challenge of the patents listed by Novartis in relation to its Ritalin (methylphenidate hydrochloride) extended-release ...
Barr filed its abbreviated new drug application containing a Paragraph IV certification for a generic Ritalin LA (methylphenidate hydrochloride) product ...
... than 3000 tablets of Methylin and methylphenidate hydrochloride, which are closely related to the drug Ritalin, to Bogenrief from May 18 to Oct. 26. ...
... than 3000 tablets of Methylin and methylphenidate hydrochloride, which are closely related to the drug Ritalin, to Bogenrief from May 18 to Oct. 26. ...
Ritalin is the brand name of methylphenidate hydrochloride, a central nervous system stimulant. To prevent a further increase of the abuse of the drug, ...
"A recent AHRQ analysis of medication expenditures found three ADHD drugs—Concerta (methylphenidate hydrochloride ), ...
Their target is Ritalin, a drug used to treat Attention Deficit Hyperactivity Disorder (ADHD) containing the active ingredient methylphenidate hydrochloride ...
Their target is Ritalin, a drug used to treat Attention Deficit Hyperactivity Disorder (ADHD) containing the active ingredient methylphenidate hydrochloride ...
Their target is Ritalin, a drug used to treat Attention Deficit Hyperactivity Disorder (ADHD) containing the active ingredient methylphenidate hydrochloride ...